Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
26 avr. 2022 09h05 HE
|
Bioventus, Inc.
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary financial...
Bioventus Announces $415 Million Offering of Senior Notes
26 avr. 2022 08h38 HE
|
Bioventus, Inc.
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that, subject to...
Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
25 avr. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., April 25, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
08 avr. 2022 09h15 HE
|
Bioventus, Inc.
DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that TheraSkin...
Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
05 avr. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on April...
Bioventus Exercises Call Option to Acquire CartiHeal
04 avr. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised...
Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
16 mars 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will...
Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance
10 mars 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
01 mars 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug...
Bioventus Appoints Mark Singleton as Chief Financial Officer
28 févr. 2022 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has appointed...